As I had mentioned in my previous posts on the evolution of my value investment philosophy, I’ve recently been focusing more on microcap stocks trading on the OTCBB and Pink Sheets.

While many stock screeners aggregate data for most stocks on the OTCBB, Pink Sheets are not required by law to file periodic financial statements, making a screener less useful.

Despite this, many Pink Sheets continue to file audited financial statements and press releases.

Since many investors are unwilling to purchase these types of securities, this dynamic presents a great opportunity for the willing investor, as many of the securities are significantly mis-priced.

Buffett’s Approach

At the 2001 Berkshire shareholder meeting, Buffett talked about his approach to investment research:

When I started, I went through the manuals page by page. I went through 20,000 pages in the Moody’s industrial, transportation, banks and finance manuals — twice. I actually looked at every business — although I didn’t look very hard at some.

Since the opportunities in the broader market are drying up (at least for the fundamentally cheap stocks I’m looking for), I used this as inspiration to start my own research project into all of the businesses trading on the Pink Sheets.

I would look at every possible stock and decide whether it was worth further research.

As Buffett said, I wouldn’t look very hard at the majority of the available stocks, but I was hopeful that I would find a few gems.

On the OTCMarkets website – the go-to source for Pink Sheets securities – I started with the Symbol Information File for the entire company directory.

A recent check shows 20,730 individual securities, a staggering number.

Research Methodology

A significant number of these securities consist of stocks trading on the Grey Market – a security that “is not listed, traded or quoted on any U.S. stock exchange or the OTC Markets” and has no market maker – and therefore can be avoided.

Check out the list of OTC Market tiers to better understand the various levels of disclosure.

I also removed international stocks, setting them aside for further review later. (Right now, I continue to trade through Zecco, which does not provide exposure to international markets)

For the initial stage of this project, the focus was on U.S. common stocks.

Once the list was cut down, I started going through the list one-by-one.

I’d open up each stock quote page on OTCMarket and check out the latest price quote, stock chart, and company information. I’d look at the financials, and open up the latest 10-Q and 10-K.

I could usually tell within a minute or two whether the stock warranted further analysis.

Many stocks are labeled as development or exploration companies, outside of my circle of competence and likely not generating revenues.

A large portion were banks and other financial institutions, an immediate pass for me.

Others were shell companies, continuing their public disclosure in the hopes of merging with an entity in the future.

And numerous others had no identifiable business model or updated financial information.

Consistently negative profits, tons of debt, recent or repeated share dilution (a favorite among the penny stocks) are all reasons to cross the name off of the list.

The ugliest had literally billions of shares outstanding yet traded for only fractions of a penny.

While some investors might find value in these types of securities, I decided to just pass instead of looking at them very hard.

At the same time, many of the stocks were growing, profitable businesses with long histories, but ones that had decided that the costs and compliance of Sarbanes-Oxley and full SEC reporting were not in the best interest of the company or shareholders.

If the stock passed the initial once-over, I’d usually spend time reading the full annual report, the last few quarterly filings, as well as the proxy statement and any recent press releases or insider filings.

Only then, satisfied that it was a legitimate, worthwhile business, would I add it to the watch list for full due diligence at a later date.

By the Numbers – 3698 Stocks Later

Pink Sheets Stock Chart

Final Tally: 3,698 stocks

Roughly 15% of the stocks passed my initial 2 minute due diligence check.

Of the stocks requiring further due diligence, I broke them out into subjective tiers based on their overall business model, cheapness, insider holdings, etc.

Pink Sheets Interesting Stocks Breakdown

All Tier 1 stocks required additional due diligence and number crunching to identify actual investment candidates.

To date, maybe 20-30 companies made it as candidates on my immediate watch (or buy) list.

30 out of 3698

.8%

Conclusions

There is no doubt that there are still incredible bargains out there for investors who are willing to put in the effort to comb through the undiscovered corners of the market.

A few examples:

  • A business with 50 years of history trading at 1.5x EV/EBIT & less than working capital
  • A sub $50m stock that grew revenues through 2008/2009 with an average FCF yield of 27%
  • A $300m in sales company selling for 0.65x book value, with positive net income for 9 out of 10 years

It was an incredible exercise, and definitely helped my confidence in evaluating companies through their financial statements alone.

In these stocks, the simple things matter – profits, cash flow, positive equity – and I’ve found that I prefer it that way.

It took me almost 2 months to complete this initial review, but it is a quest that never ends. I need to go back through the Tier 2 & 3 stocks for a second pass.

Final Thoughts

In a 1993 interview, Buffett talked again about his recommendation for investors who are starting out with small sums of capital and searching for undervalued opportunities.

Adam Smith: If a younger Warren Buffett were coming into the investment field today, what areas would you tell him to point himself in?

Warren Buffett: Well, if he were doing – if he were coming in and working with small sums of capital I’d tell him to do exactly what I did 40-odd years ago, which is to learn about every company in the United States that has publicly traded securities and that bank of knowledge will do him or her terrific good over time.

Smith: But there’s 27,000 public companies.

Buffett: Well, start with the A’s.

3,698 stocks later.

From A – Z.

Last week, Access Plans (APNC) reported a 69% increase in first quarter 2011 earnings, with the market reacting very favorably to the news.

The company continues to show impressive growth in its core Wholesale Plans division, while investments in the Retail Plans division are finally starting the pay off, unlocking additional shareholder value.

Despite the rapid price increase, the stock remains undervalued as long as the company can sustain the new earnings power.

Financial Overview

Overall, net revenues were up 7% to $14.3m in the first quarter of 2011 compared to $13.3m in the same quarter last year.

Operating income jumped 53% to $2.5m, while net income surged to $1.5m, an increase of 69% compared to the first quarter of FY2010.

Diluted EPS came in at $0.08, an increase of 100% compared to the first quarter last year, and up 300% over the previous quarter’s results.

From a business segment perspective, the Wholesale Plans and Retail Plans division continue to turn in impressive results.

APNC - Q1 2011 Business Segment Breakdown

Wholesale Plans

Revenues within the Wholesale division increased 20% to $6.1m versus $5.1m in the prior period. The company added 49 new Rent-a-Center locations in Puerto Rico, which turned in better than expected results.

More importantly, gross margins improved significantly, which flowed down to help boost operating income by 156% to $1.8m for the quarter.

The margin improvement was partially explained by a reduction in the company’s involuntary unemployment waiver expense, which

“Assists members with their rental payments in the event that they are laid off, fired or lose their job due to a company strike or labor dispute.”

As the U.S. economy stabilizes and job cuts decline, margins in this segment should continue to be positively impacted.

Retail Plans

APNC has aggressively rolled out new programs in the Retail Plans division, with revenues increasing 18% to $4.6m versus $3.9m in the first quarter of FY2010.

In the third and fourth quarter of 2010, the company made significant investments in an inbound call center program for the Retail Plans – temporarily depressing earnings – a decision which is showing dividends going into the new fiscal year.

These positive results do not include the impact of APNC’s new Smart Solution Plus product, a roll-out on which management is very bullish.

The new product is approved in 22 states already, and could provide a nice boost towards operating profits throughout the rest of the year.

Insurance Marketing

The Insurance Marketing division remains profitable, but revenues have continued to decline due to negative effects of the Healthcare Reform Act.

Revenues decreased 7% to $5.1m versus $5.5m in the first quarter of FY2010, while operating profits dropped to $0.04m.

In the first quarter of 2010, two major carriers pulled out of the business, so this should be the last YoY comparison impacted by this change.

The company appears to be working hard to reposition the insurance division towards a mix of supplemental benefit offerings (more closely resembling the Retail Plans division).

Balance Sheet

APNC continues to stockpile cash, growing the cash balance to $8.5m, or $0.42/shr, offset by no debt.

Risks

With the recent price increase, the company is selling significantly above its current book value of $0.79 per share. APNC must keep up the current earnings level in order to justify such a premium.

In addition, the company is still embroiled in a lawsuit, Zermeno v Precis, Inc.

Under the case, the plaintiffs are arguing that APNC’s Care Entrée discount health program violates California law as it pertains to referring people to people to a physician, hospital, health-related facility, or dispensary for any form of medical care or treatment as part of a discount program.

On January 21, 2011, the Court ruled that the defendants must stop the program in California six months after the effective date. APNC has until March 25, 2011 to appeal.

According to the company,

“An adverse outcome in this case would have a material affect our financial condition and would limit our ability (and that of other healthcare discount programs) to do business in California.”

Lawsuits are notoriously unpredictable but it is certainly something to monitor.

Conclusion

The first calendar quarter is traditionally the slowest for the company, but results should be bolstered by a full quarter of sales for the Smart Solutions Plus program.

In addition, management still sees potential growth opportunities in the wholesale plans division, and continues to evaluate strategic alternatives (both a share buyback and possible dividend were mentioned on the conference call).

I trimmed some of my position in my personal portfolio, but will be holding on to the balance as I believe there remains significant upside in the stock, especially in a going private transaction or sale.

Management was bullish on the conference call, and it appears that a FY EPS of $0.30-$0.35 is not out of the question.

Despite the run-up, the stock still trades at 7.65 EV/EBIT and 10.26 EV/FCF.

A caller during the Q/A portion of the earnings call reiterated my thinking:

“You have a cheap stock here guys”

Management’s response:

“We think so as well.”

Disclosure

Long APNC.OB

AML Communications (AMLJ.OB) Buyout Offer

Posted February 15th, 2011. Filed under Holdings Stock Updates

In a very surprising move on the day of its 3rd quarter 2011 earnings release, AML Communications (AMLJ.OB) announced that it would be acquired by Anaren, Inc. (ANEN) for $2.15 in an all-cash transaction (press release link).

The deal is worth $29.3m and is expected to close by June 30, 2011. I’ve included an excerpt of the press release below:

Anaren, Inc. (Nasdaq:ANEN) and AML Communications, Inc. (OTCBB:AMLJ) today jointly announced the signing of a definitive merger agreement whereby Anaren, through a subsidiary, has agreed to acquire all of AML’s outstanding shares of common stock for $2.15 per share in an all-cash transaction, representing an equity value of approximately $29.3 million and an enterprise value of approximately $22.6 million.

And quotes from the respective management team:

Lawrence A. Sala, Chairman, President and CEO of Anaren said, “We are very pleased to have reached this agreement with AML and believe the acquisition is consistent with Anaren’s growth, profitability, and innovation strategies. AML’s leading microwave amplifier technology is an excellent fit for the Space & Defense Group’s strategy to expand its technology base in order to capture a broader array of subsystem opportunities at our defense OEM customers.”

Jacob Inbar, Chairman, President and CEO of AML said, “We are excited about joining the Anaren team and the many new business and technology opportunities we can jointly pursue as a result. Moreover, the transaction provides our shareholders a significant premium to the recent trading price of their common stock. Being part of a larger organization will offer new and exciting opportunities for our employees; and we are confident AML’s current customers will benefit from our combined broader technology portfolio and manufacturing capabilities made possible by the acquisition.”

3rd Quarter Earnings

Before examining the transaction, a quick note on the 3rd quarter earnings.

The company reported revenues of $4.06m, down 4% from $4.26m in the same quarter last year. Net income was $333k, translating into $0.03 EPS, down one penny from the $0.04 per share last year.

The company’s cash balance grew to $4.7m compared to $3.3m in the prior-year quarter, and up sequentially from $4.5m in the quarter before.

The conference call was surprisingly brief, but Inbar did mentioned that they are still ramping up for a large order which affected this quarter’s results.

Conclusions

However, with the buyout offer on the table, the earnings become less important for the common shareholder.

The company had originally hired C.K. Cooper & Co back in July of 2010 to evaluate strategic alternatives.

After reading the press releases and listening to management on the conference calls, I thought that the talks were mostly around AMLJ acquiring another company (a viewpoint which I believe was shared by most investors).

This was confirmed in the earnings call yesterday, with Inbar explaining that the company had signed several LOIs and had explored (and documented) a wide range of possible transactions.

Either way, the news was certainly a pleasant surprise!

The deal represents a significant premium over the recent trading price of the stock, falling within the valuation range in my original writeup on AMLJ.

Using the EV number from the press release and AMLJ’s most recent EBIT and FCF figures (ttm), I calculate an EV/EBIT and EV/FCF ratio of 12x and 13.5x respectively, which seems fair.

I’m closing out my position in AMLJ in the ValueUncovered portfolio based on yesterday’s closing price of $2.08, for a gain of 64%.

Disclosure

No positions.